Back to 
Wasatch Advisors LP
Wasatch Advisors LP
KYMR
Showing 0 of 11 quarters
Position history for Wasatch Advisors LP's holdings in Kymera Therapeutics, Inc.
No. Wasatch Advisors exited its KYMR (Kymera Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 572,907 shares worth $8M. Wasatch Advisors first reported KYMR in Q2 2021 and held it in 10 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.